Solentim Overview
- Founded
- 2010
- Status
- Acquired/Merged
- Employees
- 51
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 1
- Investments
- 1
Solentim General Information
Description
Designer and developer of biotechnology solutions designed for seeding, assurance and productivity measurements. The company's technology performs total plate laser focus scanning, adjusting for plate contours, to ensure an optimal focal position for each cell, enabling research labs to accelerate projects.
Contact Information
(Operating Subsidiary)
- Solent House, Johnson Road
- Fernside Business Park, Stapehill
- Wimborne BH21 7SE
- England, United Kingdom
Solentim Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Solentim‘s full profile, request access.
Request a free trialSolentim Comparisons
Industry
000000 0
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSolentim Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000000 000000000 | Private Debt Financed | Vancouver, Canada | 0000 | 000.00 | 00000000. 00 | 000.00 |
| 00000 0000000000 | Formerly PE-Backed | Ann Arbor, MI | 000 | 000000&0 | ||
| 000000 0000000000 | Venture Capital-Backed | Singapore, Singapore | 00 | 00.00 | 00000000000 | 00.00 |
| 000000 0000000 | Formerly PE-Backed | Beverly, MA | 00 000000 |
Solentim Patents
Solentim Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-2551116-B | Dispensing method and apparatus | Active | 31-May-2016 | 000000000 | |
| GB-2551116-A | Dispensing method and apparatus | Granted | 31-May-2016 | 000000000 | |
| GB-201609508-D0 | Dispensing method and apparatus | Granted | 31-May-2016 | 000000000 | |
| US-20210163875-A1 | Cell imaging with growth matrices | Pending | 31-May-2016 | 000000000 | |
| US-20170342367-A1 | Dispensing method and apparatus | Pending | 31-May-2016 | C12M41/48 | 0 |
Solentim Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Truesdale Ph.D | Chief Executive Officer & Board Member | ||
| Catherine Petty | Financial Controller | ||
| Ian Taylor Ph.D | Chief Commercial Officer & Chief Business Officer |
Solentim Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000 | Solentim | Board Member | 000 0000 |
| 0000 000000000 00.0 | Solentim | Chief Executive Officer & Board Member | 000 0000 |
Solentim Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSolentim Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 23-Feb-2021 | 00000 0000 | Drug Discovery | 0000 0000 |